Abstract
Hyperforin, a major antidepressant constituent of St. John’s wort ( Hypericum perforatum ), exhibits high selectivity in activating the canonical transient potential channel 6 (TRPC6). Our previous studies have shown that TRPC6 may modulate Ca 2+ handling via store-operated Ca 2+ entry (SOCE) in adult ventricular myocytes. In the present study, we aim to test whether hyperforin is arrhythmogenic by facilitating Ca 2+ waves. Intracellular Ca 2+ fluorescence (F/F 0 ) was imaged in Fluo-4-AM loaded ventricular myocytes isolated from adult mice (2-4 month old). SOCE was evaluated by increasing the external Ca 2+ concentration ([Ca 2+ ] o ) from 0 to 1 mM after caffeine (10 mM) and thapsigargin (10 µM) were used to completely deplete SR Ca 2+ . Hyperforin (0.1-10 µM) perfusion increased SOCE up to 3.7 folds (F/F 0 = 3.73 ± 0.42, n = 7, compared to the control F/F 0 = 1.69 ± 0.37, n = 9, p < 0.05), in a concentration dependent fashion. Whole-cell currents were recorded using ramp pulses from -110 mV to +50 mV, while K + , Na + , L-type Ca 2+ , and Na + -Ca 2+ exchange currents were pre-blocked. Hyperforin at a lower concentration (0.1 µM) induced a significant increase of inward current (from -1.44 ± 0.23 pA/pF to -2.56 ± 0.36 pA/pF, n = 8, p < 0.05), which was then inhibited by the SOCE blocker Gd 3+ (1 mM) (-0.43 ± 0.22 pA/pF, n = 8, p < 0.05). Hyperforin promotes spontaneous CaWs ([Ca 2+ ] o 4 mM) by increasing the frequency to 180± 14 % (n = 11. p < 0.05), which can be attenuated by Gd 3+ (1 mM), or SKF-96265 (10 μM). In addition, both the amplitudes of Ca 2+ transients (F/F 0 =1.92 ± 0.09 to 2.09 ± 0.10, n = 12, p < 0.05) and calcium content (control: F/F 0 = 2.03 ± 0.11, n=16 to 2.12 ± 0.13, n = 11, p < 0.05) were enhanced by acute hyperforin perfusion (0.1 µM), when the cells were paced at a pacing cycle length of 2 seconds. The proarrhythmic effect of hyperforin was also confirmed in Langendorff-perfused hearts, from which optical membrane voltage mapping and EKG were simultaneously recorded. In conclusion, the TRPC6 activator hyperforin exhibits an arrhythmogenic effect in the heart. Its action is likely to be mediated by generating an inward current and increasing the calcium load in cardiac myocytes through the SOCE pathway. Caution should be taken when prescribing this drug to patients with heart disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.